LeeatKeren Weizmann Institute of ScienceIsrael

LeeatKeren
Dr. Keren completed her B.Sc. in Tel-Aviv University and her M.Sc. and Ph.D. in computational biology at the Weizmann Institute of Science with Prof. Eran Segal and Prof. Ron Milo. In 2016 she joined the lab of Dr. Michael Angelo in Stanford University as a Fulbright, EMBO and Damon Runyon fellow to spearhead the development of MIBI-TOF, a platform for multiplexed imaging of tissues. In 2020 she joined the faculty of the Department of Molecular Cell Biology at the Weizmann Institute of Science. Dr. Keren’s research focuses on studying tumor-immune interactions using multiplexed imaging. She develops computational tools that allow to tease various layers of information from rich multiplexed-imaging data and employ them to infer design principles in tumor immunology.

Tuesday 09 June 2026

Time Session
13:30
14:15
Lunaphore and Advanced Cell Diagnostics – Bio-techne brands: Transforming Tissue into Insight: Spatial Biology Solutions for Precision Oncology
Dr. Wiesner will highlight how Advanced Cell Diagnostics and Lunaphore, Bio-Techne brands, are transforming the future of oncology research and precision medicine with spatial biology tools. Dr. Karen, from the Weizmann Institute of Science, will talk about how modern lung cancer treatment depends on multiple biomarkers, but current diagnostic workflows exhaust small biopsies and slow down life-saving therapy decisions. Her team developed a multiplexed imaging approach that reads dozens of markers from one tissue section, enabling comprehensive diagnosis while conserving tissue and shortening turnaround time.
Room F9+10
15:20
16:55
Symposium: Plasticity and Non-genetic Cancer Evolution
Room F1+2+3